QuidelOrtho Welcomes Micah Young as New Chief Financial Officer for Strategic Growth

QuidelOrtho Welcomes Micah Young as Chief Financial Officer

QuidelOrtho Corporation, a prominent global player in the diagnostic solutions arena, has made a significant leadership change by appointing Micah Young as its new Chief Financial Officer (CFO). The announcement was made on June 23, 2026, with Young set to officially take on his role starting July 6, 2026. This shift comes after Joseph M. Busky, the previous CFO, announced his retirement, paving the way for a seamless transition as he takes on an advisory position.

Micah Young brings a wealth of experience to QuidelOrtho, having held several key leadership roles within the medical technology sector over the span of two decades. His most recent position was as Executive Vice President and CFO at Masimo Corporation, where he played a crucial role in steering the company through a strategic transformation marked by operational improvements and enhanced investor engagement since his appointment in 2017. Prior to his time at Masimo, Young also held senior finance roles at NuVasive, Inc. and contributed to finance and accounting efforts at Zimmer Holdings, Inc., starting his career with Deloitte Touche LLP.

In his new position, Young will focus on advancing the company's financial performance, enhancing cash flow management, and driving execution efficiency. Brian J. Blaser, QuidelOrtho’s President and CEO, expressed confidence in Young's abilities, stating, "His expertise will be vital as we work towards improving profitability and creating long-term value for our shareholders."

Young’s substantial expertise in capital allocation and strong background in investor relations are expected to align well with QuidelOrtho’s ongoing initiatives to boost profitability and financial health. "I am incredibly honored to join QuidelOrtho at a pivotal time for the company," said Young in a statement. "I look forward to collaborating with Brian and the leadership team to strengthen our operational discipline and create sustainable value across all stakeholders."

QuidelOrtho continues to prioritize advancements in diagnostics as an integral part of its mission to improve global health outcomes. The company has made a name for itself in clinical chemistry, immunoassay, and molecular testing, striving for rapid, accurate, and reliable diagnostic results that enhance patient care across various healthcare settings.

As demand for innovative diagnostic solutions continues to rise, Young's arrival signals a robust commitment to not only maintaining QuidelOrtho's legacy of innovation but also driving it further in an ever-evolving medical landscape.

For more updates, visit QuidelOrtho's official website and follow them on their social media platforms to stay informed about their mission, values, and innovative contributions to the healthcare sector.

In summary, the appointment of Micah Young as CFO of QuidelOrtho represents a continuing commitment to strengthen financial discipline and operational excellence. His experience in managing substantial transformation within global public companies positions him as a vital asset to the leadership team and the company’s long-term objectives.

Contact Information

For investor inquiries, please reach out to Juliet Cunningham, Vice President of Investor Relations. For media queries, contact Stephanie Kleewein, Senior Corporate Communications and PR Manager. Both are readily available to provide insights following this strategic leadership change.